This report aims to serve as a compendium of information that provides an overview of existing national, regional and global regulatory frameworks and policy initiatives that address EDCs. In particular, the report has a focus on frameworks that explicitly address EDCs (i.e., frameworks that consider both adverse effects and their endocrine causes in the assessment of chemical(s)). Explicit frameworks from countries and regions across five continents are identified and information essential for understanding their basic functioning is summarized (including their scope and general processes, public participation and stakeholder involvement, processes relevant for EDCs, criteria utilized, and data requirements).